... North America L.P. acquired a new position in shares of CymaBay Therapeutics in the 2nd quarter valued at $242,000. Ardsley Advisory Partners boosted its position in shares of CymaBay Therapeutics by 66.2% in the 2nd quarter. Ardsley Advisory ...
http://ift.tt/2hA1l3g
No comments:
Post a Comment